What is the equivalent dosage of 40mg oxycodone to Dilaudid (hydromorphone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid Conversion: Oxycodone 40mg to Hydromorphone (Dilaudid)

Direct Answer

40mg of oral oxycodone converts to approximately 4mg of oral hydromorphone (Dilaudid), but you should start with 2-3mg oral hydromorphone (50-75% dose reduction) to account for incomplete cross-tolerance. 1

Conversion Calculation

Step 1: Convert to Morphine Milligram Equivalents (MME)

  • Oxycodone has a conversion factor of 1.5 to morphine equivalents 1
  • 40mg oxycodone × 1.5 = 60 MME per day 1, 2, 3

Step 2: Convert MME to Hydromorphone

  • Hydromorphone has a conversion factor of 5.0 (meaning hydromorphone is 5 times more potent than morphine) 1
  • 60 MME ÷ 5.0 = 12mg oral hydromorphone per day 1, 3
  • However, if this is a single 40mg dose (not daily total), then: 40mg oxycodone = 60 MME ÷ 5.0 = 12mg hydromorphone total daily dose

For a Single Dose Equivalent

  • If 40mg oxycodone is a single dose given 3 times daily (120mg total daily), the calculation differs
  • For a direct single-dose conversion: 40mg oxycodone ÷ 10 = 4mg hydromorphone (using the approximate 10:1 oral oxycodone to oral hydromorphone ratio) 1

Critical Safety Reduction

You must reduce the calculated equianalgesic dose by 25-50% when switching opioids 1, 2, 3

Recommended Starting Doses:

  • Conservative approach (50% reduction): Start with 2mg oral hydromorphone 1, 3
  • Moderate approach (25-37.5% reduction): Start with 2.5-3mg oral hydromorphone 1, 2
  • This reduction accounts for incomplete cross-tolerance between different opioids and individual pharmacokinetic variability 1

Route-Specific Considerations

If Converting to IV/Subcutaneous Hydromorphone:

  • Oral hydromorphone is approximately 5 times less potent than IV hydromorphone 3, 4
  • 4mg oral hydromorphone ≈ 0.8mg IV hydromorphone 3, 4
  • With 50% safety reduction: start with 0.4mg IV hydromorphone 3, 4

Clinical Implementation Algorithm

For Controlled Pain on Current Regimen:

  1. Calculate full equianalgesic dose (4mg oral hydromorphone for 40mg oxycodone) 1
  2. Reduce by 50%: Start with 2mg oral hydromorphone 1, 3
  3. Provide immediate-release hydromorphone 0.5-1mg every 4 hours PRN for breakthrough 2, 3
  4. Reassess within 24-48 hours and titrate based on breakthrough medication use 2, 3

For Poorly Controlled Pain:

  1. May start with 100% of equianalgesic dose or increase by 25% 1
  2. Start with 4-5mg oral hydromorphone 1, 3
  3. Monitor closely for respiratory depression 3

Important Caveats and Pitfalls

Variability in Conversion Ratios:

  • The oxycodone to hydromorphone ratio ranges from approximately 8:1 to 10:1 in the literature 5, 6
  • Significant variability exists between clinicians and conversion resources, with standard deviations often exceeding 50% of mean values 6
  • These are estimates only and cannot account for individual genetics and pharmacokinetics 1

High-Dose Considerations:

  • At higher opioid doses (≥30mg IV hydromorphone equivalent), lower conversion ratios may be needed 4
  • The conversion ratio from IV hydromorphone to oral morphine equivalents decreases from 11.54 to 9.86 at doses ≥30mg/day 4

Monitoring Requirements:

  • Close monitoring for respiratory depression and oversedation is essential after any opioid conversion 3
  • Reassess pain control and adverse effects within 24-48 hours 2, 3
  • Adjust dose based on breakthrough medication requirements 2, 3

Patient-Specific Factors to Consider:

  • Age, renal/hepatic function, and prior opioid exposure affect dosing 3
  • Previous opioid dose influences conversion ratios when switching 5
  • Reasons for switching (inadequate analgesia vs. adverse effects) impact appropriate dosing 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Equivalencia de Dosis entre Oxicodona y Morfina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Opioid Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Variability in Opioid Equivalence Calculations.

Pain medicine (Malden, Mass.), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.